| Literature DB >> 28813679 |
Yangchun Xie1, Shan Zhu2, Xinxin Song3, Xiaofang Sun2, Yong Fan2, Jinbao Liu2, Meizuo Zhong4, Hua Yuan5, Lin Zhang6, Timothy R Billiar3, Michael T Lotze3, Herbert J Zeh3, Rui Kang3, Guido Kroemer7, Daolin Tang8.
Abstract
Ferroptosis is a form of regulated cell death that may facilitate the selective elimination of tumor cells. The tumor suppressor p53 (TP53) has been demonstrated to promote ferroptosis via a transcription-dependent mechanism. Here, we show that TP53 limits erastin-induced ferroptosis by blocking dipeptidyl-peptidase-4 (DPP4) activity in a transcription-independent manner. Loss of TP53 prevents nuclear accumulation of DPP4 and thus facilitates plasma-membrane-associated DPP4-dependent lipid peroxidation, which finally results in ferroptosis. These findings reveal a direct molecular link between TP53 and DPP4 in the control of lipid metabolism and may provide a precision medicine strategy for the treatment of colorectal cancer by induction of ferroptosis.Entities:
Keywords: ACSL4; NOX; NRF2; SLC7A11; TP53; ddp4; ferroptosis; iron; lipid peroxidation; precision medicine
Mesh:
Substances:
Year: 2017 PMID: 28813679 DOI: 10.1016/j.celrep.2017.07.055
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423